CPRIT PDR — Texas Seed Company
Funds early Texas oncology companies in seed stages while strengthening oncology-specific research development.
The Cancer Prevention and Research Institute of Texas (CPRIT) Texas Seed Company RFA is the entry-level track within the Product Development Research program, which deploys approximately $70 million per fiscal year to Texas oncology companies. The Seed RFA funds company formation and early-stage research and development across all oncology product categories — therapeutics, devices, diagnostics, a…
Company formation and early-stage R&D of novel oncology therapeutics, devices, diagnostics, and enabling tools in Texas, capped at $3 million per project.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline